Unknown

Dataset Information

Progression-free survival and overall survival after BRCA1/2-associated epithelial ovarian cancer: A matched cohort study.


ABSTRACT:

Introduction

Germline BRCA1/2-associated epithelial ovarian cancer has been associated with better progression-free survival and overall survival than sporadic epithelial ovarian cancer, but conclusive data are lacking.

Methods

We matched 389 BRCA1-associated and 123 BRCA2-associated epithelial ovarian cancer patients 1:1 to sporadic epithelial ovarian cancer patients on year of birth, year of diagnosis, and FIGO stage (< = IIA/> = IIB). Germline DNA test was performed before or after epithelial ovarian cancer diagnosis. All patients received chemotherapy. We used Cox proportional hazards models to estimate the associations between mutation status (BRCA1 or BRCA2 versus sporadic) and progression-free survival and overall survival. To investigate whether DNA testing after epi

SUBMITTER: Heemskerk-Gerritsen BAM 

PROVIDER: S-EPMC9498928 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature